Theravance Biopharma Inc (TBPH) Financials

TBPH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 469.8 million 180.1 million
March 31, 2026 472.3 million 181.7 million
Dec. 31, 2025 485.6 million 188.8 million
Sept. 30, 2025 415.5 million 182.8 million

TBPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -8.9 million 6.0 million
March 31, 2026 73.3 million 4.5 million
Dec. 31, 2025 -6.1 million 4.5 million
Sept. 30, 2025 -6.5 million 4.6 million

TBPH Net Income

No data available :(

TBPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 387.7 million - 38.6 million
March 31, 2026 394.7 million 32.8 million 29.8 million
Dec. 31, 2025 315.4 million 32.8 million 31.8 million
Sept. 30, 2025 329.7 million - 44.6 million

TBPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 51.7 million
March 31, 2026 51.3 million
Dec. 31, 2025 53.1 million
Sept. 30, 2025 51.9 million

TBPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 4.7 million 14.2 million -
March 31, 2026 - 5.8 million 17.7 million -
Dec. 31, 2025 8000 7.0 million 19.9 million -
Sept. 30, 2025 - 8.1 million 18.3 million -

TBPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 20.7 million 1.4 million
March 31, 2026 17.7 million 1.4 million
Dec. 31, 2025 45.9 million 1.5 million
Sept. 30, 2025 20.0 million 8.1 million

TBPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TBPH

Price: $17.03

52 week price:
13.08
21.03

Payout Ratio Range:
-661.83%
-457.78%

Earnings Per Share: 1.04 USD

P/E Ratio: 16.32

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Cayman Islands

Volume: 260600

Ebitda: -62.9 million

Market Capitalization: 882.6 million

Links: